PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.75%
Revenue growth above 1.5x 3141.T's 0.40%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
10.29%
Gross profit growth above 1.5x 3141.T's 0.84%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
11.03%
EBIT growth below 50% of 3141.T's 938.35%. Michael Burry would suspect deeper competitive or cost structure issues.
42.26%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
26.24%
Net income growth under 50% of 3141.T's 3308.38%. Michael Burry would suspect the firm is falling well behind a key competitor.
26.24%
EPS growth under 50% of 3141.T's 3439.76%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
26.24%
Diluted EPS growth under 50% of 3141.T's 3437.35%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.00%
Slight or no buybacks while 3141.T is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.65%
10Y revenue/share CAGR under 50% of 3141.T's 160.57%. Michael Burry would suspect a lasting competitive disadvantage.
-2.00%
Negative 5Y CAGR while 3141.T stands at 44.73%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-30.84%
Negative 3Y CAGR while 3141.T stands at 25.52%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Negative 10Y OCF/share CAGR while 3141.T stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Negative 5Y OCF/share CAGR while 3141.T is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
No Data
No Data available this quarter, please select a different quarter.
51.37%
Below 50% of 3141.T's 220.92%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
22.70%
Positive 5Y CAGR while 3141.T is negative. John Neff might view this as a strong mid-term relative advantage.
-13.67%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
62.70%
Below 50% of 3141.T's 184.43%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
33.26%
5Y equity/share CAGR at 50-75% of 3141.T's 52.53%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
-10.59%
Negative 3Y equity/share growth while 3141.T is at 22.73%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-45.83%
Cut dividends over 10 years while 3141.T stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
41.30%
Dividend/share CAGR of 41.30% while 3141.T is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-26.14%
Negative near-term dividend growth while 3141.T invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
25094.44%
AR growth well above 3141.T's 24.81%. Michael Burry fears inflated revenue or higher default risk in the near future.
-1.93%
Inventory is declining while 3141.T stands at 4.09%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.97%
Asset growth well under 50% of 3141.T's 10.37%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
5.74%
Similar to 3141.T's 5.63%. Walter Schloss finds parallel capital usage or profit distribution strategies.
54.19%
We have some new debt while 3141.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-41.59%
We cut SG&A while 3141.T invests at 7.79%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.